Advanced Materials · 2023 · 72 citations · 37 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer ImmunotherapyCancer MetabolismGlioblastomaMetabolic ReprogrammingMetabolic Reprogramming In CancerTargeted Cancer TherapyGlioblastoma ImmunotherapyGlioblastoma MetabolismGlioblastoma Targeted TherapyGlioblastoma Tumor MicroenvironmentImmunogenic Cell Death InductionImmunosuppressive MicroenvironmentProgrammed Cell Death Protein 1 (Pd-1) PathwayTumor Microenvironment Regulation
Abstract The metabolic reprogramming of glioblastoma (GBM) poses a tremendous obstacle to effective immunotherapy due to its impact on the immunosuppressive microenvironment. In this work, a hydrogen‐bonded organic framework (HOF) specifically designed for GBM immunotherapy is developed, taking advantage of the relatively isolated cholesterol metabolism microenvironment in the central nervous system (CNS). The HOF‐based biotuner regulates extra/intracellular cholesterol metabolism, effectively blocking the programmed cell death protein 1/programmed death‐ligand 1 (PD‐1/PD‐L1) pathway and reducing 2B4 expression. This metabolically disrupts the immunosuppressive microenvironment of GBM and rejuvenates CD8 + T cells. Moreover, cholesterol metabolism regulation offers additional benefits in treating GBM invasion. Furthermore, tumor microenvironment (TME)‐initiated chemiexcited photodynamic therapy (PDT) is enhanced during the regulation of cholesterol metabolism, and the biotuner can effectively trigger immunogenic cell death (ICD) and increase the infiltration of cytotoxic T lymphocytes (CTLs) in GBM. By reversing the immunosuppressive microenvironment and bolstering chemiexcited‐PDT, this approach invigorates efficient antibody non‐dependent immunotherapy for GBM. This study provides a model for enhancing immunotherapy through cholesterol metabolism regulation and explores the feasibility of a “metabolic checkpoint” strategy in GBM treatment.
37
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau, Igor Smirnov, Timothy Keyes et al. · Nature · 2015 · 4.3K citations
Medicine, Anatomy, Neurobiology +14
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin, Annabelle Anandappa, Jing Sun et al. · Nature · 2018 · 1.4K citations · Full text
Medicine, Immunology, Oncology +16
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone, Liang Zhao, Judson M. Englert et al. · Science · 2019 · 1.2K citations
Medicine, Immunology, Oncology +17
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen, Chao Wang, Xudong Zhang et al. · Nature Nanotechnology · 2018 · 1K citations
Medicine, Immunology, Oncology +10